Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 249 articles:
HTML format



Single Articles


    December 2022
  1. MONGARDINI FM
    Author Spotlight: Federico Maria Mongardini.
    Dig Dis Sci. 2022;67:5433.
    PubMed    


  2. TURBAYNE AK, Sparrow MP
    Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo.
    Dig Dis Sci. 2022;67:5382-5391.
    PubMed     Abstract available


  3. PEYRIN-BIROULET L, Bouguen G, Laharie D, Pellet G, et al
    Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study.
    Dig Dis Sci. 2022;67:5637-5646.
    PubMed     Abstract available


  4. KAAZAN P, Tan Z, Maiyani P, Mickenbecker M, et al
    Weight and BMI Patterns in a Biologicals-Treated IBD Cohort.
    Dig Dis Sci. 2022;67:5628-5636.
    PubMed     Abstract available


  5. LEE KE, Lim F, Faye AS, Shen B, et al
    Endoscopic Balloon Dilation Is Cost-Effective for Crohn's Disease Strictures.
    Dig Dis Sci. 2022;67:5462-5471.
    PubMed     Abstract available


    November 2022
  6. SHERRILL GC, Esckilsen S, Hudson J, Kochar B, et al
    Relationship Between Stages of Ileal Pouch-Anal Anastomosis, Timing of Restoration of Fecal Continuity, and Pouchitis.
    Dig Dis Sci. 2022;67:5220-5226.
    PubMed     Abstract available


  7. HERMAN HS, Rosenthaler MP, Elhassan N, Weinberg JM, et al
    COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Diseases at a Diverse Safety Net Hospital.
    Dig Dis Sci. 2022;67:5029-5033.
    PubMed     Abstract available


  8. KOCHAR BD, Cheng D, Cai T, Ananthakrishnan AN, et al
    Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:5206-5212.
    PubMed     Abstract available


  9. SIEBER A, Aberra FN, Bonhomme B, McKeever L, et al
    Influence of Corticosteroid Use on Short- and Long-Term Outcomes of Biologic Therapy for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:5168-5176.
    PubMed     Abstract available


    October 2022
  10. BARRETT CM, Long MD, Grimm I, Herfarth HH, et al
    Off the Cuff Markers: Surveillance and Endoscopic Approaches for Dysplasia After Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2022;67:4666-4670.
    PubMed    


  11. SULTAN K, Trindade AJ
    Concise Commentary: Is Splitting the Difference? Identifying Risk Factors Associated with Suboptimal Bowel Preparation for Colonoscopy Among IBD Patients.
    Dig Dis Sci. 2022;67:4602-4603.
    PubMed    


  12. ZAND A, Stokes Z, Sharma A, van Deen WK, et al
    Artificial Intelligence for Inflammatory Bowel Diseases (IBD); Accurately Predicting Adverse Outcomes Using Machine Learning.
    Dig Dis Sci. 2022;67:4874-4885.
    PubMed     Abstract available


  13. SIGALA-ROBLES R, Santiago-Lopez L, Hernandez-Mendoza A, Vallejo-Cordoba B, et al
    Peptides, Exopolysaccharides, and Short-Chain Fatty Acids from Fermented Milk and Perspectives on Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:4654-4665.
    PubMed     Abstract available


  14. SYAL G, Sparrow MP, Velayos F, Cheifetz AS, et al
    Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology.
    Dig Dis Sci. 2022;67:4687-4694.
    PubMed     Abstract available


  15. SUCHMAN K, Luo Y, Grinspan A
    Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
    Dig Dis Sci. 2022;67:4866-4873.
    PubMed     Abstract available


    September 2022
  16. MIYAZAKI H, Watanabe D, Ito Y, Okamoto N, et al
    Side Effects of COVID-19 Vaccines in Patients with Inflammatory Bowel Disease in Japan.
    Dig Dis Sci. 2022 Sep 30. pii: 10.1007/s10620-022-07703.
    PubMed     Abstract available


  17. SONNENBERG A
    Similar Time Trends of Hodgkin Lymphoma, Multiple Sclerosis, and Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Sep 27. pii: 10.1007/s10620-022-07705.
    PubMed     Abstract available


  18. ASHAT D, Jain A, Weaver KN, Long MD, et al
    An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Sep 20. pii: 10.1007/s10620-022-07682.
    PubMed    


  19. CHODEN T, Yeager M, Cohen RD
    Checking Out the Associations Between Inflammatory Bowel Disease and Checkpoint Inhibitor Colitis.
    Dig Dis Sci. 2022 Sep 13. pii: 10.1007/s10620-022-07668.
    PubMed    


  20. SPENCER EA, Dolinger MT, Dubinsky MC
    A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Sep 5. pii: 10.1007/s10620-022-07684.
    PubMed     Abstract available


  21. SINGH A, Midha V, Mahajan R, Verma S, et al
    Evaluation of Nutritional Characteristics Reveals Similar Prevalence of Malnutrition in Patients with Ulcerative Colitis and Crohn's Disease.
    Dig Dis Sci. 2022 Sep 5. pii: 10.1007/s10620-022-07652.
    PubMed     Abstract available


  22. DAI C, Jiang M, Huang YH
    Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Dig Dis Sci. 2022 Sep 5. pii: 10.1007/s10620-022-07648.
    PubMed    


  23. CHUGH R, Mahadevan U
    Advanced Fellowship Training in IBD: A Worthwhile Fourth Year.
    Dig Dis Sci. 2022;67:4339-4341.
    PubMed    


  24. HOLLANDER D
    DDS Perspective: Crohn's Disease and Increased Intestinal Permeability-Initial Demonstration and Birth Pains.
    Dig Dis Sci. 2022;67:4337-4338.
    PubMed    


  25. SUAREZ RG, Osornio-Vargas AR, Wine E
    Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review.
    Dig Dis Sci. 2022;67:4342-4354.
    PubMed     Abstract available


  26. BARNES EL
    Treating IBD? Don't Forget that Mental Health Matters.
    Dig Dis Sci. 2022;67:4321-4323.
    PubMed    


  27. ROSIOU K, Selinger CP
    Using the PIDA on Your PDA: Providing Personalized Education and Decision Support for Women with IBD of Childbearing Age.
    Dig Dis Sci. 2022;67:4315-4316.
    PubMed    


  28. DA SILVA MTB, Dos Santos AA
    Proinflammatory Effects of Wheat and Rye in an IBD Model: Give Us Not Our Daily Bread.
    Dig Dis Sci. 2022;67:4324-4325.
    PubMed    


  29. AVILA F, Caron B, Hossu G, Ambarki K, et al
    Magnetic Resonance Elastography for Assessing Fibrosis in Patients with Crohn's Disease: A Pilot Study.
    Dig Dis Sci. 2022;67:4518-4524.
    PubMed     Abstract available


    August 2022
  30. TEICH N, Stallmach A, Bruns T
    Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis.
    Dig Dis Sci. 2022 Aug 24. pii: 10.1007/s10620-022-07670.
    PubMed    


  31. WANG G, Tandon P, Rodriguez N, Ambrosio L, et al
    Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients.
    Dig Dis Sci. 2022 Aug 5. pii: 10.1007/s10620-022-07638.
    PubMed     Abstract available


  32. MAAS LA, Krishna M, Parian AM
    Ironing It All Out: A Comprehensive Review of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2022 Aug 5. pii: 10.1007/s10620-022-07599.
    PubMed     Abstract available


  33. KOUNTOURAS J, Papaefthymiou A, Polyzos SA, Liatsos C, et al
    Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Aug 5. pii: 10.1007/s10620-022-07642.
    PubMed    


  34. UZZAN M
    Tofacitinib: A Small Molecule for Biologic-Refractory Crohn's Disease?
    Dig Dis Sci. 2022;67:3479-3480.
    PubMed    


  35. LEE SD, Singla A, Harper J, Barahimi M, et al
    Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.
    Dig Dis Sci. 2022;67:4043-4048.
    PubMed     Abstract available


  36. FLESHNER PR
    Concise Commentary: Crystallomancy and Ileal Pouch Surgery.
    Dig Dis Sci. 2022;67:4032.
    PubMed    


  37. GIRI S, Sundaram S
    Low Dose Azathioprine with Allopurinol in IBD: Early Days to Call It a Recipe for Success.
    Dig Dis Sci. 2022;67:4263-4265.
    PubMed    


  38. VAN LIERE ELSA, Bayoumy AB, Mulder CJJ, Warner B, et al
    Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:4008-4019.
    PubMed     Abstract available


  39. LINDHOLM M, Di Sabatino A, Manon-Jensen T, Mazza G, et al
    A Serological Biomarker of Laminin Gamma 1 Chain Degradation Reflects Altered Basement Membrane Remodeling in Crohn's Disease and DSS Colitis.
    Dig Dis Sci. 2022;67:3662-3671.
    PubMed     Abstract available


  40. DASHARATHY SS, Limketkai BN, Sauk JS
    What's New in the Postoperative Management of Crohn's Disease?
    Dig Dis Sci. 2022;67:3508-3517.
    PubMed     Abstract available


    July 2022
  41. DAI C, Jiang M, Huang YH
    Neutrophil-to-Lymphocyte Ratio for the Diagnosis and Monitoring of Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jul 22. pii: 10.1007/s10620-022-07593.
    PubMed    


  42. SELINGER CP
    Introduction to the DDS MiniIssue: "Inflammatory Bowel Disease and Pregnancy".
    Dig Dis Sci. 2022 Jul 13. pii: 10.1007/s10620-022-07603.
    PubMed    


  43. COHEN NA, Zafer M, Setia N, Anderson MJ, et al
    Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07607.
    PubMed     Abstract available


  44. PICETTI D, Kim J, Zhu W, Sandborn WJ, et al
    No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy.
    Dig Dis Sci. 2022;67:3115-3123.
    PubMed     Abstract available


  45. HONAP S, Sharma E, Samaan MA
    5-ASAs in Crohn's Disease: Time to Stop the Salicylate?
    Dig Dis Sci. 2022;67:2699-2700.
    PubMed    


  46. AFIF W, Sattin B, Dajnowiec D, Khanna R, et al
    Ustekinumab Therapeutic Drug Monitoring-Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial.
    Dig Dis Sci. 2022;67:3148-3157.
    PubMed     Abstract available


  47. OIZUMI T, Mayanagi T, Toya Y, Sugai T, et al
    NLRP3 Inflammasome Inhibitor OLT1177 Suppresses Onset of Inflammation in Mice with Dextran Sulfate Sodium-Induced Colitis.
    Dig Dis Sci. 2022;67:2912-2921.
    PubMed     Abstract available


  48. KOSTEV K, Loosen S, Roderburg C
    Prevalence of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:3471.
    PubMed    


  49. SINGH G, Haileselassie Y, Ji AR, Maecker HT, et al
    Protective Effect of Saffron in Mouse Colitis Models Through Immune Modulation.
    Dig Dis Sci. 2022;67:2922-2935.
    PubMed     Abstract available


  50. PABLA BS, Alex Wiles C, Slaughter JC, Scoville EA, et al
    Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor alpha Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience.
    Dig Dis Sci. 2022;67:3129-3137.
    PubMed     Abstract available


  51. NAKASHIMA T, Fujii K, Seki T, Aoyama M, et al
    Novel Gut Microbiota Modulator, Which Markedly Increases Akkermansia muciniphila Occupancy, Ameliorates Experimental Colitis in Rats.
    Dig Dis Sci. 2022;67:2899-2911.
    PubMed     Abstract available


  52. GARG R, Aggarwal M, Butler R, Achkar JP, et al
    Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease Patients.
    Dig Dis Sci. 2022;67:3138-3147.
    PubMed     Abstract available


  53. SASSON AN, Ananthakrishnan AN
    High Anti-Infliximab Antibody Titers Do Not Impact Response to Subsequent Adalimumab Treatment in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:3124-3128.
    PubMed     Abstract available


    June 2022
  54. GU D, Cao T, Yi S, Liu Y, et al
    CCCTC-Binding Factor Mediates the Transcription of Insulin-Like Growth Factor Binding Protein 5 Through EZH2 in Ulcerative Colitis.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07566.
    PubMed     Abstract available


  55. BARNES A, Ooi SJ, Lynch KD, Parthasarathy N, et al
    Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07556.
    PubMed     Abstract available


  56. KUMAR A, Swaminath A
    Impatience with Inpatients: Are Hospitalization Rates Declining for IBD Patients?
    Dig Dis Sci. 2022;67:1927-1929.
    PubMed    


  57. NGUYEN NH, Zhang X, Long MD, Sandborn WJ, et al
    Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:2039-2048.
    PubMed     Abstract available


  58. GORDON H, Blad W, Trier Moller F, Orchard T, et al
    UK IBD Twin Registry: Concordance and Environmental Risk Factors of Twins with IBD.
    Dig Dis Sci. 2022;67:2444-2450.
    PubMed     Abstract available


  59. ROCCHI C, Soliman YY, Massidda M, Vadala di Prampero SF, et al
    Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.
    Dig Dis Sci. 2022;67:1948-1955.
    PubMed     Abstract available


  60. SINGH S, Heien HC, Sangaralingham L, Shah ND, et al
    Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-alpha Antagonists in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:2510-2516.
    PubMed     Abstract available


  61. SERVAIS L, Boschetti G, Meunier C, Gay C, et al
    Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis.
    Dig Dis Sci. 2022;67:2492-2502.
    PubMed     Abstract available


  62. WATANABE Y, Mizushima T, Okumura R, Fujino S, et al
    Fecal Stream Diversion Changes Intestinal Environment, Modulates Mucosal Barrier, and Attenuates Inflammatory Cells in Crohn's Disease.
    Dig Dis Sci. 2022;67:2143-2157.
    PubMed     Abstract available


  63. COSTABLE NJ, Borman ZA, Ji J, Dubinsky MC, et al
    Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab.
    Dig Dis Sci. 2022;67:2480-2484.
    PubMed     Abstract available


  64. XIE M, Xiong Z, Yin S, Xiong J, et al
    Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation.
    Dig Dis Sci. 2022;67:2232-2243.
    PubMed     Abstract available


    May 2022
  65. ZHANG M, Xie Z, Zhou G, Wang Y, et al
    Conflicting Effects of Wnt-5a in Ulcerative Colitis: You Wnt Some, You Lose Some.
    Dig Dis Sci. 2022 May 31. pii: 10.1007/s10620-022-07542.
    PubMed    


  66. KUMAR A, Shenoy V, Buckley MC, Durbin L, et al
    Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Dig Dis Sci. 2022 May 27. pii: 10.1007/s10620-022-07530.
    PubMed     Abstract available


  67. UCHIYAMA K, Takagi T, Mizushima K, Asaeda K, et al
    Investigation on the Inhibitory Effect of Wnt-5a on Colonic Mucosal Inflammation in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 May 19. pii: 10.1007/s10620-022-07537.
    PubMed     Abstract available


  68. GOTTLIEB ZS, Dolinger M, Kayal M, Rao BB, et al
    Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy-Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07532.
    PubMed    


  69. SIMSEK-ONAT P, Hizarcioglu-Gulsen H, Ergen YM, Gumus E, et al
    Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07547.
    PubMed     Abstract available


  70. BUERKLE KS, Vernon-Roberts A, Ho C, Schultz M, et al
    A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 May 5. pii: 10.1007/s10620-022-07507.
    PubMed     Abstract available


  71. HILL E, Nguyen NH, Qian AS, Patel S, et al
    Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07505.
    PubMed     Abstract available


  72. CON D, Vasudevan A
    Real-World Guidance from Artificial Intelligence? Predicting Outcomes of Inflammatory Bowel Disease Using Machine Learning.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07511.
    PubMed    


  73. BRENNER EJ, Long MD, Kappelman MD, Zhang X, et al
    Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07517.
    PubMed     Abstract available


  74. GEORGOPOULOS I, Mavrigiannaki E, Stasinopoulou S, Renieris G, et al
    Experimental Intestinal Stenosis Alters Crohn's Disease-Like Intestinal Inflammation in Ileitis-Prone Mice.
    Dig Dis Sci. 2022;67:1783-1793.
    PubMed     Abstract available


    April 2022
  75. WANG G, Karimi N, Willmann L, Pipicella J, et al
    A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Apr 30. pii: 10.1007/s10620-022-07494.
    PubMed     Abstract available


  76. FAN Y, Delgado-Aros S, Valdecantos WC, Janak JC, et al
    Characteristics of Patients with Crohn's Disease With or Without Perianal Fistulae in the CorEvitas Inflammatory Bowel Disease Registry.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07491.
    PubMed     Abstract available


  77. DALAL RS, McClure EL, Marcus J, Allegretti JR, et al
    Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naive Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 Apr 12. pii: 10.1007/s10620-022-07472.
    PubMed     Abstract available


  78. EMERSON C, Skvarc D, Fuller-Tyszkiewicz M, Olive L, et al
    Self-Worth Beliefs Predict Willingness to Engage in Psychotherapy for Fatigue in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Apr 8. pii: 10.1007/s10620-022-07476.
    PubMed     Abstract available


  79. CAPLAN A, McConnell R, Velayos F, Mahadevan U, et al
    Delayed Initiation of Rescue Therapy Associated with Increased Length of Stay in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Apr 7. pii: 10.1007/s10620-022-07490.
    PubMed     Abstract available


  80. DE JONG ME, Nagtegaal ID, Vos S, van der Post RS, et al
    Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
    Dig Dis Sci. 2022 Apr 5. pii: 10.1007/s10620-022-07485.
    PubMed     Abstract available


  81. MACEDO SILVA V, Freitas M, Boal Carvalho P, Dias de Castro F, et al
    Apex Score: Predicting Flares in Small-Bowel Crohn's Disease After Mucosal Healing.
    Dig Dis Sci. 2022;67:1278-1286.
    PubMed     Abstract available


  82. TSIAOUSSIS GI, Christaki E
    Is the APEX Score the Pinnacle of Predictive Scoring Systems of Disease Flare in Crohn's Patients with Documented Mucosal Healing?
    Dig Dis Sci. 2022;67:1092-1094.
    PubMed    


  83. HORST S
    Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?
    Dig Dis Sci. 2022;67:1090-1091.
    PubMed    


  84. DAI C, Huang YH
    Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery.
    Dig Dis Sci. 2022;67:1421-1422.
    PubMed    


  85. LEE HS, Chiorean MV, Boden E, Lord J, et al
    Usefulness of Fluoroscopy for Endoscopic Balloon Dilation of Crohn's Disease-Related Strictures.
    Dig Dis Sci. 2022;67:1295-1302.
    PubMed     Abstract available


    March 2022
  86. DEKA D, D'Inca R, Sturniolo GC, Das A, et al
    Role of ER Stress Mediated Unfolded Protein Responses and ER Stress Inhibitors in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Mar 22. pii: 10.1007/s10620-022-07467.
    PubMed     Abstract available


  87. SASSON G, Kirby CH, Hamilton MJ, Winter RW, et al
    Serving Up a Mediterranean Remission in Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 19. pii: 10.1007/s10620-022-07447.
    PubMed    


  88. SLEUTJES JAM, Roeters van Lennep JE, de Vries AC
    Spotlight on Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Mar 18. pii: 10.1007/s10620-022-07449.
    PubMed    


  89. AJBAR A, Cross E, Matoi S, Hay CA, et al
    Diagnostic Delay in Pediatric Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07452.
    PubMed     Abstract available


  90. CORCORAN RM, MacDonagh P, O'Connell F, Morrissey ME, et al
    Association Between Ex Vivo Human Ulcerative Colitis Explant Protein Secretion Profiles and Disease Behaviour.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07411.
    PubMed     Abstract available


  91. AKIYAMA S, Ollech JE, Traboulsi C, Rai V, et al
    Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07405.
    PubMed     Abstract available


  92. AKIYAMA S, Cohen NA, Steinberg JM, Friedberg S, et al
    Rare and Well Done: Endoscopic Control of Colonic Hemorrhage in Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 7. pii: 10.1007/s10620-022-07446.
    PubMed    


  93. XIAO Y, Benoit N, Sedano R, Jairath V, et al
    Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07439.
    PubMed     Abstract available


  94. GUILLO L, Amiot A, Serrero M, Altwegg R, et al
    Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07445.
    PubMed     Abstract available


  95. YU Y, Zhao H, Luo Y, Lou J, et al
    Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy.
    Dig Dis Sci. 2022;67:997-1006.
    PubMed     Abstract available


  96. YI Y, Sossenheimer PH, Erondu AI, Skowron KB, et al
    Using Wearable Biosensors to Predict Length of Stay for Patients with IBD After Bowel Surgery.
    Dig Dis Sci. 2022;67:844-853.
    PubMed     Abstract available


    February 2022
  97. WU RY, Tandon P, Ambrosio L, Dunsmore G, et al
    Post-neonatal Outcomes of Infants Born to Women with Active Trimester One Inflammatory Bowel Disease: A Pilot Study.
    Dig Dis Sci. 2022 Feb 24. pii: 10.1007/s10620-022-07430.
    PubMed     Abstract available


  98. FUJIYA M, Kawaguchi T, Arai S, Isogawa N, et al
    Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07388.
    PubMed     Abstract available


  99. PEMMASANI G, Loftus EV, Tremaine WJ
    Prevalence of Pulmonary Diseases in Association with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Feb 10. pii: 10.1007/s10620-022-07385.
    PubMed     Abstract available


  100. FAYE AS
    Connecting the Dots: IBD and Frailty.
    Dig Dis Sci. 2022;67:406-407.
    PubMed    


  101. HUDHUD D, Stashek K, George L, Cross RK, et al
    An Adalimumab-Induced Mucosal Red Storm in a Patient with Crohn's Disease.
    Dig Dis Sci. 2022;67:453-456.
    PubMed    


  102. SHARMA N, Savelkoul E, Disney B, Shah A, et al
    A Multicenter Study of Patient Acceptability of the IBD Disk Tool and Patient-Reported Disabilities.
    Dig Dis Sci. 2022;67:457-462.
    PubMed     Abstract available


  103. HANZEL J, Almradi A, Istl AC, Yang ML, et al
    Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis.
    Dig Dis Sci. 2022;67:646-660.
    PubMed     Abstract available


    January 2022
  104. KIM SH, Park Y, Kim SP, Lee SH, et al
    Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data.
    Dig Dis Sci. 2022 Jan 30. pii: 10.1007/s10620-021-07328.
    PubMed     Abstract available


  105. CLARKE K, Pelton M, Stuart A, Tinsley A, et al
    COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jan 29. pii: 10.1007/s10620-021-07377.
    PubMed     Abstract available


  106. KOBAYASHI M, Yamashita R, Ichikawa R, Shibutani M, et al
    Ectopically Localized Epithelial Cell Clumps in Ulcers Are Derived from Reserved Crypt Stem Cells in a Mouse Model of Ulcerative Colitis.
    Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07340.
    PubMed     Abstract available


  107. VELAYOS FS, Lee JK
    Endoscopic Surveillance and Dysplasia Management in IBD: Plus Ca Change, Plus C'est la Meme Chose.
    Dig Dis Sci. 2022;67:81-84.
    PubMed    


  108. LITTLE RD, Chu IE, Ward MG, Sparrow MP, et al
    De-escalation from Dose-Intensified Anti-TNF Therapy Is Successful in the Majority of IBD Patients at 12 Months.
    Dig Dis Sci. 2022;67:259-262.
    PubMed     Abstract available


  109. SHIGA H, Abe I, Kusaka J, Shimoyama Y, et al
    Capsule Endoscopy Is Useful for Postoperative Tight Control Management in Patients with Crohn's Disease.
    Dig Dis Sci. 2022;67:263-272.
    PubMed     Abstract available


    December 2021
  110. HONG SJ, Katz S
    Frailty, Thy Diagnosis Is Uncertain: Impact on IBD Readmission and Mortality.
    Dig Dis Sci. 2021;66:4070-4071.
    PubMed    


  111. VEYRE F, Boschetti G, Meunier C, Cuerq C, et al
    Low Levels of Fecal Calprotectin 3 Months After Surgery Predict Subsequent Endoscopic Postoperative Remission in Crohn's Disease.
    Dig Dis Sci. 2021;66:4429-4435.
    PubMed     Abstract available


  112. FAYE AS, Wen T, Soroush A, Ananthakrishnan AN, et al
    Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD.
    Dig Dis Sci. 2021;66:4178-4190.
    PubMed     Abstract available


    November 2021
  113. DOU D, Ji Y, Zheng J, Li J, et al
    A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4(+)T Cells into Th1 Cells.
    Dig Dis Sci. 2021 Nov 9. pii: 10.1007/s10620-021-07300.
    PubMed     Abstract available


  114. LU J, Liu D, Tan Y, Li R, et al
    Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5.
    Dig Dis Sci. 2021;66:3803-3812.
    PubMed     Abstract available


  115. HONG SJ, Jang J, Berg D, Kirat T, et al
    Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.
    Dig Dis Sci. 2021;66:3753-3759.
    PubMed     Abstract available


    October 2021
  116. XU F, Carlson SA, Liu Y, Greenlund KJ, et al
    Urban-Rural Differences in Health Care Utilization for Inflammatory Bowel Disease in the USA, 2017.
    Dig Dis Sci. 2021 Oct 11. pii: 10.1007/s10620-021-07264.
    PubMed     Abstract available


  117. RABINOWITZ LG, Zylberberg HM, Yang J, Gold SL, et al
    De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Oct 6. pii: 10.1007/s10620-021-07257.
    PubMed     Abstract available


  118. RAKOWSKY ST, Feuerstein JD
    Highs and Lows of Proactive Therapeutic Drug Monitoring in Crohn's Patients.
    Dig Dis Sci. 2021;66:3226-3227.
    PubMed    


  119. LUO Y, Cheng Q, Fang Y, Yu J, et al
    Infliximab Therapy in Very Early Onset Crohn's Disease: Real-World Experience in China.
    Dig Dis Sci. 2021;66:3555-3562.
    PubMed     Abstract available


  120. ZHANG J, Li Y, Diao Y, Da B, et al
    Long-Term Outcome of Endoscopic Balloon Dilation for Duodenal Crohn's Disease-Associated Strictures.
    Dig Dis Sci. 2021;66:3570-3577.
    PubMed     Abstract available


  121. YARUR AJ, Deepak P, Vande Casteele N, Battat R, et al
    Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:3563-3569.
    PubMed     Abstract available


  122. BORREN NZ, Paulides E, Frinack JL, Olson RN, et al
    Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study.
    Dig Dis Sci. 2021;66:3548-3554.
    PubMed     Abstract available


    September 2021
  123. SELINGER CP, Rafferty H, Mooney P, Donnellan C, et al
    Utility of Fecal Calprotectin in Routine Clinical Practice Is Impaired by Poor Sample Return Rates.
    Dig Dis Sci. 2021;66:3209-3210.
    PubMed    


  124. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.
    PubMed    


  125. DE SA BRITO FROES R, da Luz Moreira A, Carneiro AJV, Moreira JPL, et al
    Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn's Disease at a Tertiary Care Center in Rio de Janeiro.
    Dig Dis Sci. 2021;66:2925-2934.
    PubMed     Abstract available


  126. ZHANG B, Su X, Xie Z, Ding H, et al
    Inositol-Requiring Kinase 1 Regulates Apoptosis via Inducing Endoplasmic Reticulum Stress in Colitis Epithelial Cells.
    Dig Dis Sci. 2021;66:3015-3025.
    PubMed     Abstract available


  127. KIM JY, Park SH, Park JC, Noh S, et al
    The Clinical Significance of Anastomotic Ulcers After Ileocolic Resection to Predict Postoperative Recurrence of Crohn's Disease.
    Dig Dis Sci. 2021;66:3132-3140.
    PubMed     Abstract available


  128. ZEZE K, Hirano A, Torisu T, Esaki M, et al
    Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn's Disease: A Retrospective Study.
    Dig Dis Sci. 2021;66:3124-3131.
    PubMed     Abstract available


  129. VARMA S, Faye AS, Kannan A, Lawlor G, et al
    Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Dig Dis Sci. 2021;66:3113-3123.
    PubMed     Abstract available


    August 2021
  130. JAMPALA N, Jain A, Herfarth HH, Long MD, et al
    Personalized Best: Toward Improving Care in Ulcerative Colitis.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07221.
    PubMed    


  131. SATO M, Fujii K, Takagi H, Shibuya I, et al
    Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07237.
    PubMed     Abstract available


  132. ISHIDA N, Miyazu T, Tamura S, Tani S, et al
    Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Aug 30. pii: 10.1007/s10620-021-07233.
    PubMed     Abstract available


  133. KAYAL M, Bhagya Rao B, Bhattacharya A, Ungaro R, et al
    Clinical Challenge: From Ulcerative Colitis to Crohn's Disease-Like Pouch Inflammation.
    Dig Dis Sci. 2021 Aug 20. pii: 10.1007/s10620-021-07220.
    PubMed    


  134. DAI C, Jiang M, Huang YH
    COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China.
    Dig Dis Sci. 2021 Aug 19. pii: 10.1007/s10620-021-07169.
    PubMed    


  135. GUERRERO VINSARD D, Karagozian R, Wakefield DB, Kane SV, et al
    Maternal Outcomes and Pregnancy-Related Complications Among Hospitalized Women with Inflammatory Bowel Disease: Report from the National Inpatient Sample.
    Dig Dis Sci. 2021 Aug 18. pii: 10.1007/s10620-021-07210.
    PubMed     Abstract available


  136. TSAI L, Nguyen NH, Ma C, Prokop LJ, et al
    Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
    Dig Dis Sci. 2021 Aug 11. pii: 10.1007/s10620-021-07200.
    PubMed     Abstract available


  137. PARRA RS, da Rocha JJR, Feres O
    Growth Delay in Inflammatory Bowel Diseases: The Importance of Surgery.
    Dig Dis Sci. 2021;66:2840-2841.
    PubMed    


  138. HOU JK
    Antibiotics for Crohn's Disease: What Are We Treating?
    Dig Dis Sci. 2021;66:2478-2480.
    PubMed    


  139. PROCTOR DD
    DDS Perspective: Deborah D. Proctor, MD.
    Dig Dis Sci. 2021;66:2489-2492.
    PubMed    


  140. PROCTOR DD
    DDS Profile: Deborah D. Proctor, MD.
    Dig Dis Sci. 2021;66:2486-2488.
    PubMed    


  141. PAUL S, Williet N, Nancey S, Veyrard P, et al
    No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification.
    Dig Dis Sci. 2021;66:2744-2749.
    PubMed     Abstract available


  142. ALIBAZ-ONER F, Ergelen R, Ergenc I, Seven G, et al
    Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Differentiate Behcet's Disease with Intestinal Involvement and Crohn's Disease.
    Dig Dis Sci. 2021;66:2750-2755.
    PubMed     Abstract available


  143. SHPOLIANSKY M, Roggenbuck D, Pinsker M, Salamon N, et al
    Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
    Dig Dis Sci. 2021;66:2619-2626.
    PubMed     Abstract available


  144. DA COSTA FERREIRA S, Sadissou IA, Parra RS, Feitosa MR, et al
    Increased HLA-G Expression in Tissue-Infiltrating Cells in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:2610-2618.
    PubMed     Abstract available


  145. CHATEAU T, Damico F, Zallot C, Mathieu N, et al
    Crohn's Disease Only Visible on Small Bowel Capsule Endoscopy: A New Entity.
    Dig Dis Sci. 2021;66:2712-2716.
    PubMed     Abstract available


  146. RHODES JM, Subramanian S, Flanagan PK, Horgan GW, et al
    Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease.
    Dig Dis Sci. 2021;66:2700-2711.
    PubMed     Abstract available


    July 2021
  147. SALWEN-DEREMER JK, Smith MT, Haskell HG, Schreyer C, et al
    Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders.
    Dig Dis Sci. 2021 Jul 30. pii: 10.1007/s10620-021-07176.
    PubMed     Abstract available


  148. NARULA N, Hu A, Nguyen GC, Rangrej J, et al
    Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07151.
    PubMed     Abstract available


  149. STEWART MJ
    Does Surveillance Increase Survival? Benefits of Periodic Colonoscopy in Patients with Ulcerative Colitis and Colorectal Cancer.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07174.
    PubMed    


  150. HEATH EM, Kim RB, Wilson A
    A Comparative Analysis of Drug Therapy, Disease Phenotype, and Health Care Outcomes for Men and Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07177.
    PubMed     Abstract available


  151. GOLOVICS PA, Gonczi L, Reinglas J, Verdon C, et al
    Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Dig Dis Sci. 2021 Jul 20. pii: 10.1007/s10620-021-07178.
    PubMed     Abstract available


  152. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2021 Jul 14. pii: 10.1007/s10620-021-07130.
    PubMed     Abstract available


  153. RAO S, Borum ML
    Evaluating IBD Patient-Initiated Electronic Communication During the SARS-CoV-2 Pandemic: A Single-Center Study.
    Dig Dis Sci. 2021;66:2468-2469.
    PubMed    


  154. DALAL RS, Lichtenstein GR
    Superiority Complex: Do Teaching Hospitals Provide Inferior Care for IBD Patients?
    Dig Dis Sci. 2021;66:2137-2139.
    PubMed    


  155. HUDHUD D, Zhu G, Twaddell W, Bafford A, et al
    "Sarc" Attack: Rectal Bleeding in an Elderly Patient with Small Bowel Crohn's Disease.
    Dig Dis Sci. 2021;66:2190-2193.
    PubMed    


  156. CALABRESE C, Dussias N, Impellizzeri G, Lauro A, et al
    CEing More-Assessing Small Bowel Crohn's with Capsule Endoscopy (CE).
    Dig Dis Sci. 2021;66:2173-2176.
    PubMed     Abstract available


    June 2021
  157. PAULIDES E, Pasma A, Erler NS, van Eijk RLA, et al
    Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07118.
    PubMed     Abstract available


  158. PAREKH R, Zhang X, Ungaro RC, Brenner EJ, et al
    Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07104.
    PubMed     Abstract available


  159. BHAT S, Limdi JK, Cross RK, Farraye FA, et al
    Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07114.
    PubMed     Abstract available


  160. GRANDMOUGIN A, D'Amico F, Remen T, Danese S, et al
    Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 22. pii: 10.1007/s10620-021-07016.
    PubMed     Abstract available


  161. FAWSON S, Dibley L, Smith K, Batista J, et al
    Developing an Online Program for Self-Management of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Patients' Needs and Wants.
    Dig Dis Sci. 2021 Jun 19. pii: 10.1007/s10620-021-07109.
    PubMed     Abstract available


  162. STONE ML, Feng M, Forster EM
    COVID-19 Pandemic Increased Anxiety Among Patients with Inflammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center.
    Dig Dis Sci. 2021 Jun 11. pii: 10.1007/s10620-021-07095.
    PubMed     Abstract available


  163. MCCURDY JD, Ellen Kuenzig M, Spruin S, Fung OW, et al
    Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge.
    Dig Dis Sci. 2021 Jun 10. pii: 10.1007/s10620-021-07064.
    PubMed     Abstract available


  164. ISHIHARA J, Arai K, Kudo T, Nambu R, et al
    Serum Zinc and Selenium in Children with Inflammatory Bowel Disease: A Multicenter Study in Japan.
    Dig Dis Sci. 2021 Jun 8. pii: 10.1007/s10620-021-07078.
    PubMed     Abstract available


  165. JEON Y, Leung D, Lis CA, Wang HL, et al
    Casting a Wider NET: Is It Crohn's or Is It Neuroendocrine Tumor?
    Dig Dis Sci. 2021;66:1802-1806.
    PubMed    


  166. ARMSTRONG J, Sarhan S
    Observations on the Effect of Electronic Needle Container on Adherence to Adalimumab.
    Dig Dis Sci. 2021;66:2135-2136.
    PubMed    


  167. ABOUBAKR A, Riggs AR, Jimenez D, Mella MT, et al
    Identifying Patient Priorities for Preconception and Pregnancy Counseling in IBD.
    Dig Dis Sci. 2021;66:1829-1835.
    PubMed     Abstract available


    May 2021
  168. EMERSON C, Fuller-Tyszkiewicz M, Orr R, Lyall K, et al
    Low Subjective Wellbeing Is Associated with Psychological Distress in People Living with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 29. pii: 10.1007/s10620-021-07065.
    PubMed     Abstract available


  169. AL KHOURY A, Balram B, Bessissow T, Afif W, et al
    Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2021 May 21. pii: 10.1007/s10620-021-07025.
    PubMed     Abstract available


  170. CARON B, Neuville E, Peyrin-Biroulet L
    Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07040.
    PubMed     Abstract available


  171. SYED A, Seoud T, Carleton NM, Thakkar S, et al
    Association Between Portal Vein Thrombosis and Pouchitis in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-06969.
    PubMed     Abstract available


  172. JOGENDRAN R, Tandon P, Kroeker KI, Dieleman LA, et al
    A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-06998.
    PubMed     Abstract available


  173. HAO Y, Yzet C, McBride RB, Stock A, et al
    Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis.
    Dig Dis Sci. 2021 May 2. pii: 10.1007/s10620-021-06970.
    PubMed     Abstract available


  174. WEN T, Faye AS, Lee KE, Friedman AM, et al
    Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06999.
    PubMed     Abstract available


  175. KOCHAR BD, Cai W, Ananthakrishnan AN
    Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06990.
    PubMed     Abstract available


  176. HASHASH JG, Mourad FH
    Perianal Fistulizing Crohn's Disease: No Shortcuts to a Deep Understanding of the Disease.
    Dig Dis Sci. 2021;66:1392-1393.
    PubMed    


  177. JIANG ZF, Zhang L
    LncRNA: A Potential Research Direction in Intestinal Barrier Function.
    Dig Dis Sci. 2021;66:1400-1408.
    PubMed     Abstract available


  178. SCHULTHEISS JPD, Altena S, Clevers MR, Baas D, et al
    Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container.
    Dig Dis Sci. 2021;66:1477-1487.
    PubMed     Abstract available


  179. ZHU M, Xu X, Feng Q, Cui Z, et al
    Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Dig Dis Sci. 2021;66:1658-1668.
    PubMed     Abstract available


  180. SINGH AK, Kumar R, Gupta P, Kumar-M P, et al
    FDG-PET-CT Enterography Helps Determine Clinical Significance of Suspected Ileocecal Thickening: A Prospective Study.
    Dig Dis Sci. 2021;66:1620-1630.
    PubMed     Abstract available


  181. ROLSTON VS, Kimmel J, Popov V, Bosworth BP, et al
    Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.
    Dig Dis Sci. 2021;66:1631-1638.
    PubMed     Abstract available


    April 2021
  182. DAI C, Huang YH
    Letter to the Editor on "Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic".
    Dig Dis Sci. 2021 Apr 29. pii: 10.1007/s10620-021-06957.
    PubMed    


  183. VIJAYVARGIYA P, Gonzalez Izundegui D, Calderon G, Tawfic S, et al
    Increased Fecal Bile Acid Excretion in a Significant Subset of Patients with Other Inflammatory Diarrheal Diseases.
    Dig Dis Sci. 2021 Apr 22. pii: 10.1007/s10620-021-06993.
    PubMed     Abstract available


  184. GUDINO V, Salas A
    Promise of Mesenchymal Stem Cell Lysates in IBD Therapy: Are the Parts Greater than the Whole?
    Dig Dis Sci. 2021;66:932-934.
    PubMed    


  185. WONG K, Isaac DM, Wine E
    Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management.
    Dig Dis Sci. 2021;66:954-964.
    PubMed     Abstract available


    March 2021
  186. SOO WT, Costello SP, Bryant RV
    Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 25. pii: 10.1007/s10620-021-06946.
    PubMed    


  187. BARBER GE, Hendler S, Choe M, Keyashian K, et al
    Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 23. pii: 10.1007/s10620-021-06947.
    PubMed     Abstract available


  188. HONAP S, Meade S, Ibraheim H, Irving PM, et al
    Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-021-06932.
    PubMed     Abstract available


  189. BAMIAS G, Kokkotis G, Gizis M, Kapizioni C, et al
    Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.
    Dig Dis Sci. 2021 Mar 9. pii: 10.1007/s10620-021-06907.
    PubMed     Abstract available


  190. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    PubMed     Abstract available


  191. CAI W, Cagan A, He Z, Ananthakrishnan AN, et al
    A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:760-767.
    PubMed     Abstract available


    February 2021
  192. BASIL M, Schwartz D, Dalal R, Horst S, et al
    Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06888.
    PubMed     Abstract available


  193. MONTENEGRO ML, Corral JE, Lukens FJ, Ji B, et al
    Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 24. pii: 10.1007/s10620-021-06899.
    PubMed     Abstract available


  194. LUO W, Tian L, Tan B, Shen Z, et al
    Update: Innate Lymphoid Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 20. pii: 10.1007/s10620-021-06831.
    PubMed     Abstract available


  195. VERMA A, Varma S, Freedberg DE, Axelrad JE, et al
    A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06877.
    PubMed     Abstract available


  196. LLANOS-CHEA A, Shapiro JM, Winter RW, Jerger L, et al
    Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series.
    Dig Dis Sci. 2021 Feb 17. pii: 10.1007/s10620-021-06884.
    PubMed     Abstract available


  197. DALAL RS, Ananthakrishnan AN, Hamilton MJ, Winter RW, et al
    Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
    Dig Dis Sci. 2021 Feb 11. pii: 10.1007/s10620-021-06852.
    PubMed    


  198. BARSKY M, Meserve J, Le H, Collins A, et al
    Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06879.
    PubMed    


  199. SHIRAISHI K, Furukawa S, Yagi S, Mori K, et al
    Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06834.
    PubMed     Abstract available


  200. JAGT JZ, Pothof CD, Buiter HJC, van Limbergen JE, et al
    Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.
    Dig Dis Sci. 2021 Feb 3. pii: 10.1007/s10620-021-06836.
    PubMed     Abstract available


  201. QI Y, Wu HM, Yang Z, Zhou YF, et al
    New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 1. pii: 10.1007/s10620-021-06837.
    PubMed     Abstract available


  202. GAIDOS JKJ, Kane SV
    Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications.
    Dig Dis Sci. 2021;66:336-337.
    PubMed    


  203. AGRAWAL G, Aitken J, Hamblin H, Collins M, et al
    Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease.
    Dig Dis Sci. 2021;66:348-358.
    PubMed     Abstract available


  204. NIV E, Ovadia B, Groisman G, Kopelman Y, et al
    CMV-Induced Severe Colonic Stricture in an Adult Crohn's Disease Patient.
    Dig Dis Sci. 2021;66:636-639.
    PubMed    


    January 2021
  205. SINH P, Tabibian JH, Biyani PS, Mehta K, et al
    Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
    Dig Dis Sci. 2021 Jan 25. pii: 10.1007/s10620-020-06818.
    PubMed     Abstract available


  206. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-021-06826.
    PubMed    


  207. IBORRA I, Puig M, Marin L, Calafat M, et al
    Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-020-06807.
    PubMed     Abstract available


  208. DEL VALLE JP, Lee GC, Serrato JC, Feuerstein JD, et al
    Recurrence of Clostridium Difficile and Cytomegalovirus Infections in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06772.
    PubMed     Abstract available


  209. TOWNSEND CM, Khanna R, Wilson AS
    A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-alpha Antagonists.
    Dig Dis Sci. 2021 Jan 11. pii: 10.1007/s10620-020-06773.
    PubMed     Abstract available


    December 2020
  210. FIORUCCI S, Carino A, Baldoni M, Santucci L, et al
    Bile Acid Signaling in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020 Dec 8. pii: 10.1007/s10620-020-06715.
    PubMed     Abstract available


  211. BORREN NZ, Tan W, Jess AT, Li PM, et al
    Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study.
    Dig Dis Sci. 2020;65:3672-3678.
    PubMed     Abstract available


  212. GAO XH, Yu GY, Khan F, Li JQ, et al
    Greater Peripouch Fat Area on CT Image Is Associated with Chronic Pouchitis and Pouch Failure in Inflammatory Bowel Diseases Patients.
    Dig Dis Sci. 2020;65:3660-3671.
    PubMed     Abstract available


  213. LUO Y, Tixier EN, Grinspan AM
    Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Dig Dis Sci. 2020;65:3647-3651.
    PubMed     Abstract available


    November 2020
  214. DULAI PS, Jairath V
    A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06707.
    PubMed     Abstract available


  215. ZHANG Y, Li X, Li Y, Li Y, et al
    DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06697.
    PubMed     Abstract available


  216. BALRAM B, Joshi H, Wong K, Kroeker KI, et al
    Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06704.
    PubMed     Abstract available


  217. DIBLEY L, Khoshaba B, Artom M, Van Loo V, et al
    Patient Strategies for Managing the Vicious Cycle of Fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support.
    Dig Dis Sci. 2020 Nov 8. pii: 10.1007/s10620-020-06698.
    PubMed     Abstract available


  218. AXELRAD JE, Sauk JS
    Gastrointestinal Infections in IBD Flares: Can PCR-Based Stool Tests Differentiate the Smoke from the Fire?
    Dig Dis Sci. 2020;65:3064-3065.
    PubMed    


  219. PASTORELLI L, Bezzio C, Saibeni S
    Hold the Foam: Why Topical Budesonide Remains Relevant for IBD Therapy.
    Dig Dis Sci. 2020;65:3066-3068.
    PubMed    


  220. SINGH M, Singh V, Schurman JV, Friesen CA, et al
    Mucosal Th17 Cells Are Increased in Pediatric Functional Dyspepsia Associated with Chronic Gastritis.
    Dig Dis Sci. 2020;65:3184-3190.
    PubMed     Abstract available


    October 2020
  221. HOURI H, Yadegar A, Zali MR
    How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?
    Dig Dis Sci. 2020 Oct 23. pii: 10.1007/s10620-020-06667.
    PubMed    


  222. SCRIBANO ML
    Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06624.
    PubMed     Abstract available


  223. NGUYEN ALH, Sparrow MP
    Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06662.
    PubMed     Abstract available


  224. KARASKOVA E, Pospisilova D, Velganova-Veghova M, Geryk M, et al
    Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06652.
    PubMed     Abstract available


  225. VAN GENNEP S, de Boer NKH, Gielen ME, Rietdijk ST, et al
    Impaired Quality of Working Life in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06647.
    PubMed     Abstract available


  226. SITKIN S, Pokrotnieks J
    Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06650.
    PubMed     Abstract available


  227. PANACCIONE R, Isaacs JD, Chen LA, Wang W, et al
    Correction to: Characterization of Creatine Kinase Levels in TofacitinibTreated Patients with Ulcerative Colitis: Results from Clinical Trials.
    Dig Dis Sci. 2020 Oct 10. pii: 10.1007/s10620-020-06638.
    PubMed     Abstract available


  228. COSTRINI NV
    Clearing of the Clouds in Inflammatory Bowel Disease Management.
    Dig Dis Sci. 2020 Oct 3. pii: 10.1007/s10620-020-06635.
    PubMed     Abstract available


  229. CAPPELL MS
    Improving the Safety of Endoscopy in Pregnancy: Approaching Gravidity with Gravitas.
    Dig Dis Sci. 2020;65:2745-2748.
    PubMed    


  230. WEINGARDEN AR, Smith P, Streett S, Triadafilopoulos G, et al
    A Failure to Communicate: Disentangling the Causes of Perianal Fistulae in Crohn's Disease and Anal Squamous Cell Cancer.
    Dig Dis Sci. 2020;65:2806-2809.
    PubMed    


    September 2020
  231. SMITH R, Hubers J, Farraye FA, Sampene E, et al
    Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06631.
    PubMed     Abstract available


  232. XIU MX, Liu YM, Chen GY, Hu C, et al
    Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis.
    Dig Dis Sci. 2020 Sep 25. pii: 10.1007/s10620-020-06611.
    PubMed     Abstract available


  233. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed     Abstract available


  234. BLESL A, Rainer F, Pollheimer M, Kump P, et al
    Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease.
    Dig Dis Sci. 2020;65:2730-2734.
    PubMed    


  235. HALLE E, Azahaf M, Duveau N, Lambin T, et al
    Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease.
    Dig Dis Sci. 2020;65:2664-2674.
    PubMed     Abstract available


  236. CERNOCH PS, Fournier N, Zeitz J, Scharl M, et al
    Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
    Dig Dis Sci. 2020;65:2654-2663.
    PubMed     Abstract available


    August 2020
  237. SCOTT FI
    Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch?
    Dig Dis Sci. 2020;65:2158-2160.
    PubMed    


  238. COATES MD, Seth N, Clarke K, Abdul-Baki H, et al
    Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease.
    Dig Dis Sci. 2020;65:2379-2387.
    PubMed     Abstract available


    July 2020
  239. BACH LE, Taleban S
    Vedolizumab (VDZ) for UC and CD: Still Safe and Effective After All These Years.
    Dig Dis Sci. 2020;65:1882-1884.
    PubMed    


  240. RIVIERE P, Laharie D
    Concise Commentary: Spaced Out-Reducing the Relapse Risk in IBD Patients by Lengthening Dosing Intervals of Anti-TNFs.
    Dig Dis Sci. 2020;65:2044-2045.
    PubMed    


  241. CRESPI M, Dulbecco P, De Ceglie A, Conio M, et al
    Strictures in Crohn's Disease: From Pathophysiology to Treatment.
    Dig Dis Sci. 2020;65:1904-1916.
    PubMed     Abstract available


  242. REINGLAS J, Gonczi L, Verdon C, Bessissow T, et al
    Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center.
    Dig Dis Sci. 2020;65:2046-2053.
    PubMed     Abstract available


  243. LI J, Liu L, Zhao Q, Chen M, et al
    Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
    Dig Dis Sci. 2020;65:1971-1979.
    PubMed     Abstract available


    June 2020
  244. GADHOK R, Gordon H, Sebepos-Rogers G, Baillie S, et al
    UK Patients of Bangladeshi Descent with Crohn's Disease Respond Less Well to TNF Antagonists Than Caucasian Patients.
    Dig Dis Sci. 2020;65:1790-1799.
    PubMed     Abstract available


  245. MCCURDY JD, Parlow S, Dawkins Y, Samji K, et al
    Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    Dig Dis Sci. 2020;65:1784-1789.
    PubMed     Abstract available


    May 2020
  246. ZAIDI D, Wine E
    Building Fences: How A20 Protects the Intestinal Mucosa in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020;65:1288-1290.
    PubMed    


  247. LATELLA G, Viscido A
    Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.
    Dig Dis Sci. 2020;65:1299-1306.
    PubMed     Abstract available


  248. PAINCHART C, Brabant S, Duveau N, Nachury M, et al
    Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
    Dig Dis Sci. 2020;65:1445-1452.
    PubMed     Abstract available


    March 2020
  249. XU M, Cen M, Shen Y, Zhu Y, et al
    Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Dig Dis Sci. 2020 Mar 20. pii: 10.1007/s10620-020-06208.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: